Healy D P, Wilk S
Department of Pharmacology, Mount Sinai School of Medicine, City University of New York, NY 10029.
Brain Res. 1993 Mar 26;606(2):295-303. doi: 10.1016/0006-8993(93)90997-2.
Glutamyl aminopeptidase (EAP, EC 3.4.11.7) selectively hydrolyzes N-terminal glutamyl and aspartyl residues from oligopeptides and is present in the brain. (Asp1)Angiotensin II (Ang II) is a substrate for EAP, and increasing evidence suggests that des(Asp1)angiotensin II (Ang III) is an active angiotensin peptide in the brain. To determine whether a relationship exists between EAP and Ang II/III in rat brain, we compared their immunocytochemical distributions. EAP-like immunoreactivity was localized primarily to the adventitial surface of cerebral microvessels throughout the forebrain. Endothelial cells, neurons and glial cells were not labeled. The immunocytochemical staining of microvessel adventitium with EAP antiserum was suggestive of labeling of perivascular pericytes since intravenous horseradish peroxidase resulted in a similar adventitial pattern of staining, in addition to pericyte cell bodies. EAP immunoreactivity was highest within circumventricular organs, areas known to contain high levels of Ang II receptors. Positively stained EAP microvessels were also concentrated in areas containing Ang II/III immunoreactive neurons or nerve terminals, including the hypothalamic paraventricular nucleus and the median eminence. The immunocytochemical localization of EAP suggests that it may be involved in a wide variety of functions within the brain, including: (i) metabolism of circulating peptides in brain areas devoid of a blood-brain barrier, (ii) metabolism of circulating peptides as a component of the blood-brain barrier, (iii) metabolism of intravascularly synthesized peptides, (iv) metabolism of hypothalamic peptides released into the portal circulation, (v) metabolism/conversion of neuronally released Ang II to Ang III in the interstitial space, and (vi) metabolism of neuronally released neuropeptides with vasoactive properties.(ABSTRACT TRUNCATED AT 250 WORDS)
谷氨酰氨肽酶(EAP,EC 3.4.11.7)可选择性地从寡肽中水解N端谷氨酰基和天冬氨酰基残基,且存在于大脑中。(Asp1)血管紧张素II(Ang II)是EAP的底物,越来越多的证据表明,脱(Asp1)血管紧张素II(Ang III)是大脑中一种活性血管紧张素肽。为了确定大鼠脑中EAP与Ang II/III之间是否存在关系,我们比较了它们的免疫细胞化学分布。EAP样免疫反应主要定位于整个前脑大脑微血管的外膜表面。内皮细胞、神经元和神经胶质细胞未被标记。用EAP抗血清对微血管外膜进行免疫细胞化学染色提示标记的是血管周围的周细胞,因为静脉注射辣根过氧化物酶除了使周细胞胞体染色外,还产生了类似的外膜染色模式。EAP免疫反应在室周器官内最高,这些区域已知含有高水平的Ang II受体。EAP阳性染色的微血管也集中在含有Ang II/III免疫反应性神经元或神经末梢的区域,包括下丘脑室旁核和正中隆起。EAP的免疫细胞化学定位表明,它可能参与大脑内的多种功能,包括:(i)在没有血脑屏障的脑区中循环肽的代谢;(ii)作为血脑屏障的组成部分参与循环肽的代谢;(iii)血管内合成肽的代谢;(iv)释放到门脉循环中的下丘脑肽的代谢;(v)在间质空间中将神经元释放的Ang II代谢/转化为Ang III;以及(vi)对具有血管活性的神经元释放的神经肽的代谢。(摘要截短于250字)